Dr. Sokolow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 Children's Way
11215 Doctors' Office Tower
Nashville, TN 37232Phone+1 615-343-7617
Summary
- Dr. Andrew Sokolow is a pediatric pulmonologist Practicing in Nashville, TN and in Murfreesboro, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from University at Buffalo School of Medicine and has been in practice 12 years. He is experienced in Duchenne muscular dystrophy, cystic fibrosis, pediatric asthma, and pediatric bronchoscopy. He is the Program director for the Pediatric Pulmonology Training Program, the Co-Director of the PPMD accredited DMD pediatric clinic and the associate pediatric CF center director.
Education & Training
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalFellowship, Pediatric Pulmonology, 2008 - 2011
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2005 - 2008
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2005
Certifications & Licensure
- TN State Medical License 2011 - 2025
- AL State Medical License 2020 - 2020
- OH State Medical License 2005 - 2016
- American Board of Pediatrics Pediatric Pulmonology
Awards, Honors, & Recognition
- Academy for Excellence in Education, Vanderbilt University School of Medicine
Publications & Presentations
PubMed
- Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Cystic Fibrosis.Stephanie L Rolsma, Andrew Sokolow, Pratish C Patel, Katherine Sokolow, Natalia Jimenez-Truque
The Journal of Infectious Diseases. 2024-09-30 - 3 citationsLongitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.Seth A Reasoner, Rachel Bernard, Adam Waalkes, Kelsi Penewit, Janessa Lewis
Mbio. 2024-02-14 - Longitudinal Profiling of the Intestinal Microbiome in Children with Cystic Fibrosis Treated with Elexacaftor-Tezacaftor-Ivacaftor.Seth A Reasoner, Rachel Bernard, Adam Waalkes, Kelsi Penewit, Janessa Lewis
Medrxiv. 2023-11-21
Journal Articles
- Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis.Chadha AD, Thomsen IP, Jimenez-Truque N, Soper NR, Jones LS, Sokolow AG, Torres VJ, Creech CB, J Cyst Fibros, 9/15/2016
- Childhood interstitial lung diseases: an 18-year retrospective analysis.Soares JJ, Deutsch GH, Moore PE, Fazili MF, Austin ED, Brown RF, Sokolow AG, Hilmes MA, Young LR., Pediatrics, 10/2013
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: